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Paraneoplastic pemphigus is a rare, life-threatening auto-
immune mucocutaneous blistering disease associated with 
underlying neoplasia, commonly lymphoproliferative tumors. 
Herein we report a case of paraneoplastic pemphigus with a 
unique autoantibody profile associated with a malignant 
thymoma. A 56-year-old female patient presented with re-
lapsing oral ulcerations accompanied by erythematous pap-
ules and patches on her extremities for 2 months. Skin and 
mucosal biopsies identified interface dermatitis with lichen-
oid lymphocytic infiltration in the upper dermis. Immuno-
blotting and enzyme-linked immunosorbent assays revealed 
that the patient had multiple autoantibodies against desmo-
glein 1, desmocollin 1, 2, 3, laminin gamma-1, envoplakin, and 
periplakin. The skin lesions completely healed following thy-
mectomy and systemic corticosteroid therapy, but the oral 
ulcerations persisted through a follow-up period of over 2 
years. (Ann Dermatol 29(2) 219∼222, 2017)
-Keywords-
Oral ulcer, Paraneoplastic  syndromes, Pemphigus, 
Thymoma
INTRODUCTION
Paraneoplastic pemphigus (PNP) is an autoimmune muco-
cutaneous disease characterized by an associated under-
lying neoplasia and the presence of multiple autoanti-
bodies against epithelial proteins1. The clinical and histo-
pathological manifestations of PNP are largely variable2. 
In some patients, the presentation resembles classic pem-
phigus and includes painful oral ulcerations and cuta-
neous blisters as its main features; in others, polymorphous 
erythematous macules, papules, or plaques are present, 
similar to those seen in erythema multiforme, lichen pla-
nus, or cutaneous graft-vs.-host disease3. The most com-
mon and characteristic clinical feature of PNP is severe 
and intractable mucositis, which may help differentiate 
the disease from pemphigus vulgaris or oral lichen planus. 
Genetic predisposition may also be associated with PNP, 
as specific HLA allele frequencies are increased in PNP 
patients, depending on ethnicity4. Herein, we report a 
case of PNP associated with a malignant thymoma in a pa-
tient who showed refractory oral ulcerations that persisted 
even after thymectomy, along with unique immunopatho-
logic features including the presence of anti-desmocollin 
and anti-laminin gamma-1 antibodies.
CASE REPORT
A 56-year-old female Korean patient presented with wide-
spread ulcerations involving her oral mucosa, and poly-
morphous cutaneous lesions over her extremities, for a 
duration of 2 months (Fig. 1A, B, D). Physical examination 
showed scattered polygonal erythematous scaly papules 
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Fig. 2. Histopathologic findings. Skin biopsies of (A) the oral mucosa lesion and (B) the foot lesion. Both of them demonstrate interface 
dermatitis with diffuse lymphocytic infiltration in the upper dermis. (B) Several necrotic keratinocytes are scattered in the epidermis 
(H&E; A, B: ×200 magnification).
Fig. 1. Clinical findings. The patient initially presented with oral ulcerations (A, B) and erythematous papules on the extremities (D). 
Oral lesions persist even 3 months following thymectomy (C). A mediastinal tumor was found on chest computed tomography (E, 
arrowheads), which was later confirmed to be a malignant thymoma. 
and plaques on her distal extremities, particularly the dor-
sal aspects of her hands and feet. Systemic therapy with 
prednisolone (up to 15 mg) for 2 months was not effective. 
Biopsies from the buccal mucosa and the skin over the 
dorsum of the foot were performed. Histopathology of 
both lesions demonstrated vacuolar degeneration of the 
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Fig. 3. Immunologic findings. (A) Indirect immunofluorescence demonstrates IgG deposition at the intercellular space of human skin 
at 1:40 dilution and (B) IgG deposition at the epithelia of rat bladder at 1:10 dilution. (C) Immunoblotting of normal human epidermal 
extracts is positive for envoplakin (210 kDa) and periplakin (190 kDa; arrows). (D) Immunoblotting of dermal extracts is positive 
for laminin gamma-1 (200 kDa). BP: bullous pemphigoid, PNP: paraneoplastic pemphigus, PV: pemphigus vulgaris, EBA: epidermolysis 
bullosa acquisita.
basal cells with lichenoid lymphocytic infiltration in the 
upper dermis. Several apoptotic keratinocytes were found 
scattered in the epidermis (Fig. 2). An initial diagnosis of 
generalized lichen planus was made based on the clin-
icopathologic findings. Systemic therapy with prednisolone 
and cyclosporine was initiated, but the oral ulcerations 
persisted during the 4 months of treatment. The refractory 
nature of her oral lesions, and the accompanying rapid 
weight loss led to a suspicion of PNP, and additional im-
munologic studies were performed. Indirect immunofluo-
rescence (IIF) studies identified IgG deposition on kerati-
nocyte cell surfaces of human skin. IIF performed by using 
rat bladder demonstrated IgG autoantibodies reactive with 
the transitional epithelia (Fig. 3A, B). Enzyme-linked im-
munosorbent assays (ELISA) were positive for desmoglein 
(Dsg) 1 (index, 34.76; positive, ≥20), desmocollin 1 
(optical density [OD], 0.451; cut-off, 0.200), 2 (OD, 
0.309; cut-off, 0.070), and 3 (OD, 0.326; cut-off, 0.120), 
and indeterminate for Dsg3 (index, 13.82; positive, ≥20). 
Immunoblotting (IB) of normal human epidermal extracts 
was positive for envoplakin and periplakin, and IB of der-
mal extracts was positive for laminin gamma-1 (Fig. 3C, D).
Computed tomography scanning, which was performed to 
search for an underlying neoplasm, demonstrated a large 
anterior mediastinal tumor (Fig. 1E). This was proven to be 
a malignant thymoma by ultrasound-guided gun biopsy. 
Total thymectomy, wedge resection of the left upper lobe 
of the lung, and pericardial resection, were performed. 
Surgical pathology confirmed the tumor as a thymoma 
with lung and pericardial extension. Owing to the pres-
ence of pleural seeding, she received 45 Gy of adjuvant 
radiotherapy postoperatively. 
Following thymectomy, adjuvant radiotherapy, and sys-
temic therapy with corticosteroids, mycophenolate mofe-
til, and cyclosporine, skin lesions cleared completely. 
There was no evidence of tumor recurrence in 19 months 
postoperatively. Follow-up ELISA for Dsg1 was converted 
to negative (index, 8.5), and Dsg3 was weakly positive 
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(index, 24.1). However, the oral ulcerations persisted 
through her follow-up period of more than 2 years. 
DISCUSSION
PNP is an autoimmune disease in which both humoral and 
cell mediated immune response against epithelial antigens 
induce skin and mucosal tissue damage. PNP has a diverse 
spectrum of clinical, pathological, and immunological 
features. Clinical features include severe, intractable muco-
sitis and polymorphous cutaneous eruptions3, ranging from 
isolated oral ulcerations to extensive cutaneous blistering. 
Histopathologic findings depend on the morphology of the 
clinical lesion, and include intraepidermal acantholysis, 
interface dermatitis, lichenoid infiltration, and apoptotic 
keratinocytes5. The mucosal and cutaneous lesions in the 
present case were characterized by lichenoid infiltration, 
which led to an initial diagnosis of lichen planus. However, 
the presence of mucositis intractable to corticosteroids and 
the histologic findings of apoptotic keratinocytes scattered 
in the entire epidermis suggested a diagnosis of PNP.
PNP is characterized by the production of multiple auto-
antibodies against various target agents, including Dsg, 
bullous pemphigoid antigen 1, desmoplakin, envoplakin, 
periplakin, and plectin. The gold standard for the diag-
nosis of PNP is the detection of the characteristic circulat-
ing autoantibodies against the 210-kDa envoplakin and 
the 190-kDa periplakin, by IB6. The present case showed 
some unique immunologic features. First, all three iso-
forms of anti-desmocollin antibodies were detected. These 
antibodies were previously reported in cases of atypical 
pemphigus, such as pemphigus herpetiformis or pemphi-
gus vegetans, and have also been described in PNP7. They 
may play a pathogenic role in the non-classical types of 
pemphigus. Second, antibodies against the 200-kDa lam-
inin gamma-1 were identified. This is the second case of 
PNP with anti-laminin gamma-1 antibodies8. The role of 
these antibodies is yet to be described. 
Although most patients with PNP exhibit circulating an-
ti-Dsg3 antibodies that contribute to blister formation, there 
are reports of identification of anti-Dsg1 antibodies alone 
on ELISA6, as seen in the present case. The pathogenesis of 
oral lesions in PNP remains unclear, but the presence of 
autoantibodies against Dsg3 and/or cell-mediated immune 
responses may play a role in damaging mucosal epithelia9. 
In general, removal of the underlying neoplasm, especially 
when the tumors are benign, may lead to clinical improve-
ment and prolonged survival in patients with PNP. 
However, there are exceptions to this. The persistent oral 
ulcerations in our patient, even following tumor removal, 
may have been caused by a persistent T-cell mediated im-
mune response resulting in interface dermatitis. This is sup-
ported by the absence of acantholysis on histology and a 
very low titer of autoantibodies directed against Dsg3.
In conclusion, we report a case of PNP associated with a 
malignant thymoma in a patient who presented with mu-
cocutaneous lesions with lichenoid infiltrations, unique 
immunopathologic features, and refractory oral ulcer-
ations that persisted even after thymectomy. Severe oral 
ulcerations presenting as the sole manifestation in PNP are 
usually refractory to treatment10. Therefore, careful consid-
erations are needed in such cases.
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